Evolv Technologies Holdings Earnings Call Transcripts
Fiscal Year 2026
-
Revenue grew 34% year-over-year in Q2 2026, with ARR up 20% and adjusted EBITDA margin expanding to 10.1%. Full-year guidance was raised, reflecting strong demand, robust customer additions, and continued operating leverage, despite some near-term margin headwinds from product mix and supply chain costs.
-
The company targets tripling revenue to $500M+ in five years with a 25% CAGR and 25%+ EBITDA margin, driven by a recurring revenue model, product innovation, and expansion in under-penetrated markets. AI-powered screening solutions, strong customer retention, and legislative momentum support long-term growth.
-
AI-driven security screening solutions are seeing rapid adoption across education, healthcare, and sports, with Q1 revenue up 45% and 2026 guidance raised. Product innovation, strong financials, and a large untapped market support continued growth.
-
Q1 revenue grew 45% year-over-year to $46.3M, with ARR up 20% and Adjusted EBITDA margin expanding to 8.5%. Raised 2026 revenue guidance to $175M-$180M, driven by strong demand across education, healthcare, sports, and enterprise, and continued growth in recurring revenue.
-
Founded to address mass violence, the company delivers AI-driven, touchless security screening for high-traffic venues, with rapid adoption across sports, education, and healthcare. Its SaaS model enables ongoing updates, and a new manufacturing partnership supports global scaling. Awareness and education remain the main growth drivers.
Fiscal Year 2025
-
Delivered strong 2025 results with 40% revenue growth, positive adjusted EBITDA, and robust ARR and RPO gains. Raised 2026 guidance, expecting 18–22% revenue growth, high single-digit EBITDA margins, and continued expansion in key verticals.
-
Q3 revenue surged 57% year-over-year to $42.9 million, with ARR up 25% and positive adjusted EBITDA. 2025 revenue guidance was raised to $142–$145 million, and 2026 is expected to see ARR growth outpace total revenue. Strong demand continues across education, healthcare, and sports.
-
Q2 2025 saw 29% revenue growth and 27% ARR growth, with positive adjusted EBITDA and cash flow. Major legal issues were resolved, a $75M credit facility was secured, and full-year revenue guidance was raised to 27–30% growth. Strong momentum spans education, healthcare, and sports.
-
Q1 2025 revenue rose 44% year over year to $32M, with ARR up 34% and adjusted EBITDA positive at $1.7M. 2025 guidance calls for 20%-25% revenue growth, positive adjusted EBITDA, and strong expansion across education, healthcare, and entertainment verticals.
Fiscal Year 2024
-
Record Q2 revenue and ARR growth were driven by strong customer acquisition and expansion in key verticals, with recurring revenue now 83% of total. Gross margin and adjusted EBITDA improved, guidance for 2024 was reaffirmed, and the company remains on track for profitability by Q2 2025.